17.71
price up icon13.89%   2.16
after-market After Hours: 17.71
loading

Septerna Inc Stock (SEPN) Latest News

pulisher
03:08 AM

Septerna (NASDAQ:SEPN) Trading Down 4.3%Time to Sell? - MarketBeat

03:08 AM
pulisher
Jan 28, 2025

Septerna (NASDAQ:SEPN) Sets New 52-Week LowTime to Sell? - MarketBeat

Jan 28, 2025
pulisher
Jan 27, 2025

Septerna (NASDAQ:SEPN) Shares Gap UpTime to Buy? - MarketBeat

Jan 27, 2025
pulisher
Jan 24, 2025

Cantor Fitzgerald Forecasts Septerna FY2025 Earnings - Defense World

Jan 24, 2025
pulisher
Jan 23, 2025

Septerna (NASDAQ:SEPN) Trading 5.7% HigherShould You Buy? - MarketBeat

Jan 23, 2025
pulisher
Jan 23, 2025

Brokers Set Expectations for Septerna FY2025 Earnings - MarketBeat

Jan 23, 2025
pulisher
Jan 23, 2025

Modest Final Quarter Completes Shaky Biotech IPO Comeback For 2024 - News & Insights

Jan 23, 2025
pulisher
Jan 20, 2025

Septerna to Introduce Groundbreaking GPCR Drug Discovery Innovations - Defense World

Jan 20, 2025
pulisher
Jan 13, 2025

Septerna (NASDAQ:SEPN) Sets New 52-Week Low – Here’s What Happened - Defense World

Jan 13, 2025
pulisher
Jan 11, 2025

Septerna (NASDAQ:SEPN) Sets New 12-Month LowTime to Sell? - MarketBeat

Jan 11, 2025
pulisher
Jan 10, 2025

Septerna (NASDAQ:SEPN) Trading Down 8.5%Here's Why - MarketBeat

Jan 10, 2025
pulisher
Jan 09, 2025

Septerna (NASDAQ: SEPN) Appoints Gil Labrucherie as Chief Financial Officer - Defense World

Jan 09, 2025
pulisher
Jan 07, 2025

Third Rock-backed Maze Therapeutics reveals profit in US IPO filing - Marketscreener.com

Jan 07, 2025
pulisher
Jan 06, 2025

Septerna appoints new CFO to bolster financial strategy By Investing.com - Investing.com Australia

Jan 06, 2025
pulisher
Jan 06, 2025

Septerna (NASDAQ:SEPN) Shares Gap DownTime to Sell? - MarketBeat

Jan 06, 2025
pulisher
Jan 06, 2025

Septerna Expands Leadership with Appointment of Industry Veteran Gil Labrucherie as Chief Financial Officer - The Manila Times

Jan 06, 2025
pulisher
Jan 06, 2025

Septerna Brings in Gil Labrucherie as Finance Chief - MarketWatch

Jan 06, 2025
pulisher
Jan 06, 2025

Septerna appoints new CFO to bolster financial strategy - Investing.com

Jan 06, 2025
pulisher
Jan 06, 2025

Septerna Names Biotech Veteran Gil Labrucherie as CFO, Brings $1.5B Capital Raising Success - StockTitan

Jan 06, 2025
pulisher
Jan 03, 2025

Septerna (NASDAQ:SEPN) Trading 7.7% HigherShould You Buy? - MarketBeat

Jan 03, 2025
pulisher
Dec 30, 2024

Septerna initiated with an Overweight at JPMorgan - MSN

Dec 30, 2024
pulisher
Dec 30, 2024

Septerna (NASDAQ:SEPN) Shares Down 5%Time to Sell? - MarketBeat

Dec 30, 2024
pulisher
Dec 26, 2024

Septerna (NASDAQ:SEPN) Sets New 52-Week High – Should You Buy? - Defense World

Dec 26, 2024
pulisher
Dec 23, 2024

Septerna (NASDAQ:SEPN) Trading Up 8.4%Time to Buy? - MarketBeat

Dec 23, 2024
pulisher
Dec 18, 2024

Septerna to Present at the 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times

Dec 18, 2024
pulisher
Dec 18, 2024

Septerna to Present GPCR Drug Discovery Pipeline at J.P. Morgan Healthcare Conference 2025 - StockTitan

Dec 18, 2024
pulisher
Dec 04, 2024

Vertex Global reports ten IPOs, acquisitions worldwide in 2024 - Tech in Asia

Dec 04, 2024
pulisher
Nov 27, 2024

Septerna, Inc.’s (NASDAQ:SEPN) Quiet Period Set To Expire on December 4th - Defense World

Nov 27, 2024
pulisher
Nov 26, 2024

New MRGPRX2 antagonists disclosed in Septurna patent - BioWorld Online

Nov 26, 2024
pulisher
Nov 23, 2024

Cantor Fitzgerald Weighs in on Septerna FY2024 Earnings - Defense World

Nov 23, 2024
pulisher
Nov 22, 2024

Analysts Offer Predictions for Septerna FY2024 Earnings - MarketBeat

Nov 22, 2024
pulisher
Nov 21, 2024

Septerna, Inc. Reports Q3 2024 Financials and Progress - Yahoo Finance

Nov 21, 2024
pulisher
Nov 21, 2024

Septerna (NASDAQ:SEPN) Coverage Initiated at Wells Fargo & Company - Defense World

Nov 21, 2024
pulisher
Nov 21, 2024

Cantor Fitzgerald Begins Coverage on Septerna (NASDAQ:SEPN) - Defense World

Nov 21, 2024
pulisher
Nov 21, 2024

Septerna (NASDAQ:SEPN) Coverage Initiated at TD Cowen - Defense World

Nov 21, 2024
pulisher
Nov 20, 2024

Septerna started by J.P. Morgan at overweight, GPCR platform cited - MSN

Nov 20, 2024
pulisher
Nov 20, 2024

Septerna Inc. (SEPN) reports earnings - Quartz

Nov 20, 2024
pulisher
Nov 20, 2024

Septerna proposes terms for upsized $175M IPO - MSN

Nov 20, 2024
pulisher
Nov 20, 2024

Septerna Shares Fall 7% After Wider 3Q Loss - MarketWatch

Nov 20, 2024
pulisher
Nov 20, 2024

Septerna Reports Third Quarter 2024 Financial Results and Recent Business Highlights - The Manila Times

Nov 20, 2024
pulisher
Nov 20, 2024

Septerna Advances Key Drug Trial, Reports $137.5M Cash Position After Successful IPO | SEPN Stock News - StockTitan

Nov 20, 2024
pulisher
Nov 20, 2024

Cantor launches Septerna stock coverage, highlighting platform value and growth in GPCR drug development - Investing.com Nigeria

Nov 20, 2024
pulisher
Nov 20, 2024

TD Cowen optimistic on Septerna stock as preclinical data fuels confidence - Investing.com Canada

Nov 20, 2024
pulisher
Nov 20, 2024

JPMorgan bullish on Septerna stock—pipeline strategy drives optimism - Investing.com India

Nov 20, 2024
pulisher
Nov 19, 2024

Septerna Poised For Biopharma Breakthrough: Analysts Cite GPCR Innovation And 2025 Milestones - AOL

Nov 19, 2024
pulisher
Nov 19, 2024

Septerna started by J.P. Morgan at overweight, GPCR platform cited (NASDAQ:SEPN) - Seeking Alpha

Nov 19, 2024
pulisher
Nov 19, 2024

This Apollo Global Management Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga

Nov 19, 2024
pulisher
Nov 19, 2024

Septerna (NASDAQ:SEPN) Coverage Initiated at Cantor Fitzgerald - MarketBeat

Nov 19, 2024
pulisher
Nov 19, 2024

Septerna (NASDAQ:SEPN) Now Covered by TD Cowen - MarketBeat

Nov 19, 2024
pulisher
Nov 19, 2024

Septerna (NASDAQ:SEPN) Earns Overweight Rating from Analysts at JPMorgan Chase & Co. - MarketBeat

Nov 19, 2024
pulisher
Nov 19, 2024

Septerna (NASDAQ:SEPN) Earns Overweight Rating from Analysts at Wells Fargo & Company - MarketBeat

Nov 19, 2024
pulisher
Nov 19, 2024

JPMorgan bullish on Septerna stock—pipeline strategy drives optimism By Investing.com - Investing.com Canada

Nov 19, 2024
$352.30
price down icon 5.49%
$41.04
price up icon 0.79%
$22.36
price up icon 3.33%
$5.41
price up icon 3.84%
biotechnology ONC
$226.89
price up icon 0.08%
$120.88
price down icon 0.23%
Cap:     |  Volume (24h):